Epstein Secrets

ed NASA Administrator Bridenstine in Florida to watch the launch. The Wall Street Journal (11/15, Pasztor, Subscription Publication, 7.57M) reports Bridenstine told reporters at the Kennedy Space Center, "Make no mistake. Every flight is a test." But, he added, "It's also true that we need to routinely be a

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

ed NASA Administrator Bridenstine in Florida to watch the launch. The Wall Street Journal (11/15, Pasztor, Subscription Publication, 7.57M) reports Bridenstine told reporters at the Kennedy Space Center, "Make no mistake. Every flight is a test." But, he added, "It's also true that we need to routinely be a

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

ed NASA Administrator Bridenstine in Florida to watch the launch. The Wall Street Journal (11/15, Pasztor, Subscription Publication, 7.57M) reports Bridenstine told reporters at the Kennedy Space Center, "Make no mistake. Every flight is a test." But, he added, "It's also true that we need to routinely be a

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying